Environmental, Social and Governance Progress Report

Overview

The report describes Teva's 2019 ESG progress across health access, employees, responsible business and environmental performance. The company reduced greenhouse gas emissions by 17% from 2017, while its 2019 highlights included 39,288 employees and $246 million worth of medicines donated to patients. It reports GRI Standards Core option reporting and an annual UN Global Compact Communication on Progress. Scope 1 and 2 emissions were externally verified, and the report includes an independent assurance statement on its materiality assessment process.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview